# Immune patterns of the tumor microenvironment in PD-L1+ EGFR+ HNSCC patients received anti-PD-1 and EGFR-based neoadjuvant therapy

**Authors:** Yuan Zhi, Wenhao Ren, Shaoming Li, Jingjing Zheng, Jianzhong Song, Ling Gao, Keqian Zhi

PMC · DOI: 10.1016/j.gendis.2025.101902 · Genes & Diseases · 2025-10-24

## Full-text entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, PDCD1 (programmed cell death 1) [NCBI Gene 5133] {aka ADMIO4, AIMTBS, CD279, PD-1, PD1, SLEB2}
- **Diseases:** HNSCC (MESH:D000077195), tumor (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12989833/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12989833/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12989833/full.md

---
Source: https://tomesphere.com/paper/PMC12989833